| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.30B | +20.1% |
| Cost of Revenue | $1.24B | +14.0% |
| Gross Profit | $4.07B | +22.1% |
| R&D Expense | $613.8M | +19.8% |
| SG&A Expense | $211.3M | +25.0% |
| Operating Income | $1.24B | +28.0% |
| Interest Expense | $21.0M | +16.7% |
| Pre-tax Income | $1.33B | +39.6% |
| Income Tax | $143.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.40B | -16.9% |
| Accounts Receivable | $1.40B | +11.1% |
| Inventory | $484.8M | +83.2% |
| Current Assets | $4.43B | +16.2% |
| Total Assets | $7.26B | +16.6% |
| Current Liabilities | $3.72B | +20.8% |
| Long-term Debt | $992.3M | +0.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.94B | +11.8% |
| Investing Cash Flow | -$649.3M | -185.0% |
| Financing Cash Flow | -$1.57B | +26.3% |
| +366.9% |
| Net Income | $1.15B | +33.9% |
| EPS (Basic) | $1.47 | +36.1% |
| EPS (Diluted) | $1.46 | +37.7% |
| Total Liabilities |
| $7.72B |
| +18.6% |
| Stockholders' Equity | -$463.4M | -64.6% |